Does MHRA provide any requirements on how the TMF Index (TMF Table Of Contents) should look like. I mean what information should be captured in the TMF Index. Currently in our organization (A Pharmaceutical Company), the TMF Index comprises of a table with three columns. First column documents the section numbers of the TMF, second column shows the title of the document to be filed in that section and the third column states whether the document is actually filed or not. Can anyone suggest if this format of TMF Index is adequate for Trials conducted in UK.